Increased Risk of Using Drug-Eluting Balloons Below the Knee? The Discussion Continues
- 1 June 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in CardioVascular and Interventional Radiology
- Vol. 43 (6), 948-949
- https://doi.org/10.1007/s00270-020-02447-z
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Risk of Death and Amputation with Use of Paclitaxel-Coated Balloons in the Infrapopliteal Arteries for Treatment of Critical Limb Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsJournal of Vascular and Interventional Radiology, 2020
- Drug-Coated vs Uncoated Percutaneous Transluminal Angioplasty in Infrapopliteal Arteries: Six-Month Results of the Lutonix BTK Trial2019
- Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global StudyJournal of Endovascular Therapy, 2019
- Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsJournal of the American Heart Association, 2018
- Drug-Eluting Balloon Versus Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in Critical Limb IschemiaJournal of the American College of Cardiology, 2014